Follow The Filings

EMR Emerson Electric

Industrials, filed as EMERSON ELEC CO (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 2 Owners
  • #298
  • Max 1.9%
  • Master 0.00%
  • $8.3M
  • 1 add 1 reduce

In 2026 Q3 Murphy Pohlad added to Emerson Electric, while Kentucky Trust trimmed.

Who owns this now

Largest portfolio weights among holders, up to 1.9% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Add 1.9%
  2. Kentucky Trust Co. Reduce 1.4%

Who owns EMR

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 1.9%, was 1.8% Add +0.5% 35,970 $5.6M History
Kentucky Trust Co., Kentucky Trust 1.4% Reduce −8.8% 17,421 $2.7M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EMR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EMR insider trades
  • None no insider bought on the open market
  • $7.9M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Surendralal Lanca Karsanbhai CEO
    Sale
    $1.6M 9,650 shares at $161.91 3.4% of stake
    Traded Aug 11 Filed Aug 12
    ↗
  2. Michael H. Train SVP & Chief Sustain Officer
    Sale
    $1.2M 7,329 shares at $158.99 3% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  3. Ram R. Krishnan COO
    Sale
    $1.6M 11,500 shares at $141.22 6.7% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  4. Surendralal Lanca Karsanbhai CEO
    Sale
    $811K 5,700 shares at $142.32 2% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  5. Matthew S Levatich Director
    Sale
    $239K 1,476 shares at $162.16 5.7% of stake
    Traded Feb 10 Filed Feb 12
    ↗
  6. Nicholas J. Piazza Senior VP & CPO
    Sale
    $1.1M 6,703 shares at $159.07 18% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  7. Mark A Blinn Director
    Sale
    $439K 2,876 shares at $152.62 28% of stake
    Traded Feb 5 Filed Feb 9
    ↗
  8. Surendralal Lanca Karsanbhai CEO
    Sale
    $966K 7,263 shares at $133.00 3.6% of stake
    Traded Dec 3, 2025 Filed Dec 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 34 share withholdings for taxes, 28 stock grants, 12 gifts, and 2 option exercises.

Congress

10 members of Congress traded EMR in the last three years: 10 buys and 10 sales. 13 members listed it in 2025 annual reports.

All Congress trades
  1. Kevin Hern R-OK-1Joint Partial sale $15K–$50K Sep 17 filed Oct 13
  2. Kevin Hern R-OK-1Joint Partial sale $15K–$50K Sep 14 filed Sep 25
  3. Kevin Hern R-OK-1Joint Partial sale $1K–$15K Sep 14 filed Sep 25
  4. Richard McCormick R-GA-7 Sell $1K–$15K Jul 30 filed Aug 14
  5. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  6. Richard McCormick R-GA-7 Buy $1K–$15K Nov 5, 2025 filed Dec 9, 2025

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.16B $17.49B $18.02B
Gross profit $7.43B $8.88B $9.52B
Gross margin * 49.0% 50.8% 52.8%
Net income $13.22B $1.97B $2.29B
Net margin * 87.2% 11.3% 12.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $13.82B $10.19B $8.58B
Total non-current assets * $28.93B $34.05B $33.38B
Total assets $42.75B $44.25B $41.96B
Total current liabilities $5.03B $5.74B $9.8B
Total equity $20.69B $21.64B $20.28B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.637B $3.33B $3.1B
Cash from investing $12.42B -$5.36B -$0.593B
Cash from financing -$6.82B -$2.46B -$4.51B
Net change in cash $6.25B -$4.46B -$2.04B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.